         |
|
 |
 |
|||||||||
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
eTOX at SOT 2016
Application Of A Shared Preclinical Database (eTOX) For Early Safety Assessment In Pharmaceutical Development (eTOX I). Poster num. 1675/P560.
Translating from preclinical in-life observations to human side effets (eTOX III). Poster num. 2630/P128.
An automated method to assess and document the validity of in silico models (eTOX IV). Poster num. 1097/P126.
Time Extrapolation Factors for Risk Assessment: Are Group Specific Extrapolation Factors Possible? (eTOX V). Poster num. 2684/P184.
Integrating Animal Data From The Past With Future CDISC-SEND Compliant Data (eTOX VI). Poster num. 2641/P139.
Cardiosafety in silico prediction - validation results of a multscale simulation model (eTOX VII). Poster num. 2647/P145
Analysis of the potential of chemicals to induce anemia based on compound specific properties. Poster num. 265/P148
TTC values for non-cancer endpoints: is the TTC concept applicable to compounds with pharmaceutical properties? Poster num. 3636/P328
